Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient

NCT03195452 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03195452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03195452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Completed
Start date
November 8, 2017
Completion date
May 6, 2020
Enrollment
100 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

virus-hiv